Sundt™ Carotid Shunt Retrospective Post Market Clinical Follow-up Study (PMCF)

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

April 25, 2019

Primary Completion Date

August 27, 2019

Study Completion Date

August 27, 2019

Conditions
Carotid Artery Stenosis
Interventions
DEVICE

Sundt carotid shunt

The Integra Sundt™ carotid shunts are indicated for temporary carotid artery bypass during carotid endarterectomy procedures to help protect the cerebral hemispheres from ischemia during the period of carotid artery occlusion.

Trial Locations (3)

10029

The Mount Sinai Medical Center, New York

47630

Research Institute of Deaconess Clinic, Newburgh

07601

Hackensack Meridian Health, Hackensack

All Listed Sponsors
lead

Integra LifeSciences Corporation

INDUSTRY

NCT03816202 - Sundt™ Carotid Shunt Retrospective Post Market Clinical Follow-up Study (PMCF) | Biotech Hunter | Biotech Hunter